{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:28:28Z","timestamp":1790026108009,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jacc.2016.08.063","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T16:48:16Z","timestamp":1479746896000},"page":"2272-2283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Acute Kidney Injury in Asians\u00a0With\u00a0Atrial\u00a0Fibrillation Treated\u00a0With\u00a0Dabigatran\u00a0or Warfarin"],"prefix":"10.1016","volume":"68","author":[{"given":"Yi-Hsin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Chu","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Fu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Tzu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Tai","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.08.063_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2016.08.063_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","article-title":"Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases","volume":"54","author":"Brodsky","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2016.08.063_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2016.08.063_bib4","doi-asserted-by":"crossref","first-page":"e57661","DOI":"10.1371\/journal.pone.0057661","article-title":"The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients","volume":"8","author":"An","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2016.08.063_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.063_bib6","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gft380","article-title":"Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats","volume":"29","author":"Ryan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2016.08.063_bib7","first-page":"173","article-title":"A\u00a0case of dabigatran-associated acute renal failure","volume":"112","author":"Shafi","year":"2013","journal-title":"WMJ"},{"key":"10.1016\/j.jacc.2016.08.063_bib8","first-page":"298261","article-title":"Dabigatran-related nephropathy in a patient with undiagnosed IgA nephropathy","volume":"2015","author":"Escoli","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.jacc.2016.08.063_bib9","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2015.03.577","article-title":"Changes in renal function in patients with atrial fibrillation: an analysis from the RE-LY trial","volume":"65","author":"Bohm","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.063_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12933-016-0365-x","article-title":"A\u00a0comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan","volume":"15","author":"Wu","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2016.08.063_bib11","doi-asserted-by":"crossref","first-page":"e3067","DOI":"10.1097\/MD.0000000000003067","article-title":"Nonapnea sleep disorders and the risk of acute kidney injury: a nationwide population-based study","volume":"95","author":"Lin","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2016.08.063_bib12","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2016.08.063_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.2013060610","article-title":"Long-term risk of coronary events after AKI","volume":"25","author":"Wu","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2016.08.063_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2016.08.063_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/STROKEAHA.115.011476","article-title":"Cardiovascular, bleeding, and mortality risks of dabigatran in Asians with nonvalvular atrial fibrillation","volume":"47","author":"Chan","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2016.08.063_bib16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2016.08.063_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000337918","article-title":"5\/6 Nephrectomy as a validated rat model mimicking human warfarin-related nephropathy","volume":"35","author":"Ozcan","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2016.08.063_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s10157-004-0305-z","article-title":"Gas6, warfarin, and kidney diseases","volume":"8","author":"Yanagita","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacc.2016.08.063_bib19","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1681\/ASN.2010101110","article-title":"Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation","volume":"22","author":"Ware","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2016.08.063_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/CIA.S44242","article-title":"Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation","volume":"8","author":"Chang","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jacc.2016.08.063_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40264-015-0290-z","article-title":"Oral anticoagulants and risk of nephropathy","volume":"38","author":"Narasimha Krishna","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2016.08.063_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jth.13229","article-title":"Anticoagulation-related nephropathy","volume":"14","author":"Wheeler","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2016.08.063_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ajh\/hpu129","article-title":"Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?","volume":"28","author":"Ware","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2016.08.063_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/pds.3791","article-title":"Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis","volume":"24","author":"Caldeira","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2016.08.063_bib25","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1253\/circj.CJ-12-0454","article-title":"Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation: the J-ROCKET AF study","volume":"76","author":"Hori","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2016.08.063_bib26","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.063_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.08.063_bib28","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2016.08.063_bib29","doi-asserted-by":"crossref","first-page":"e004301","DOI":"10.1136\/bmjopen-2013-004301","article-title":"Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation","volume":"4","author":"Cameron","year":"2014","journal-title":"BMJ Open"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716362787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716362787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:13:14Z","timestamp":1760015594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716362787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":29,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0735109716362787"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.08.063","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Kidney Injury in Asians\u00a0With\u00a0Atrial\u00a0Fibrillation Treated\u00a0With\u00a0Dabigatran\u00a0or Warfarin","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.08.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}